Chemotherapy in case the tumor is cancerous. Radiation therapy to prevent the cancerous cells from developing. Ovarian low malignant potential tumors
The tumor forms in the ovaries and gradually spreads to the outside of ovary. This mostly affects younger women and also hinders the reproductive system.Causes:
Causes are debatable and these may occur to both pregnant women and women who do not opt for pregnancy
Symptoms:
Abdominal pain or swelling. Bowel problems or constipation.Treatment:
Depending on the size of the tumor, choice of pregnancy, the spreading of the tumor, age and choices, removing the affected ovary is the most common treatment. In rare situations, the tumor is taken out of the ovary. Also, hysterectomy can be an option. Polycystic ovary syndrome
This is a hormonal imbalance, where androgens (also called male hormones) are elevated.The increased level of androgens may result in irregular menstrual cycle and diabetes and heart problem in the long run. It also affects the body in various ways like problem getting pregnant, sleep apnea, depression and anxiety, can enhance the risk of endometrial cancer. Symptoms:

Irregular periods. Heavy bleeding during periods. Excess hair growth on face and other parts of the body like chest, back, belly. Acne. Weight gain. Darkening of skin. Headaches.Treatment:

Oral contraceptives to promote regular periods
Healthier lifestyle.Other conditions include:

Ovarian cancer
Luteoma
Hypogonadism
Hyperthecosis

References


== External links ==
Due to the lack of evidence supporting the efficacy of cholinesterase inhibitors in individuals with MCI, the AAN guideline stated that clinicians who choose to prescribe them for the treatment of MCI must inform patients about the lack of evidence supporting this therapy. The guideline also indicated that clinicians should recommend that individuals with MCI engage in regular physical exercise for cognitive symptomatic benefits; clinicians may also recommend cognitive training, which appears to provide some symptomatic benefit in certain cognitive measures.As MCI may represent a prodromal state to clinical Alzheimers disease, treatments proposed for Alzheimers disease, such as antioxidants and cholinesterase inhibitors, could potentially be useful; however, as of January 2018, there is no evidence to support the efficacy of cholinesterase inhibitors for the treatment of mild cognitive impairment. Two drugs used to treat Alzheimers disease have been assessed for their ability to treat MCI or prevent progression to full Alzheimers disease. Rivastigmine failed to stop or slow progression to Alzheimers disease or to improve cognitive function for individuals with mild cognitive impairment;  donepezil showed only minor, short-term benefits and was associated with significant side effects. Intervention
Current evidence suggests that cognition-based interventions do improve mental performance (i.e. memory, executive function, attention, and speed) in older adults and people with mild cognitive impairment. Especially, immediate and delayed verbal recall resulted in higher performance gains from memory training.